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Introduction
Rubella is a mild febrile viral exanthematous disease 
transmitted through droplets or direct contact with the 
nasopharyngeal secretion of an infected person. It is of public 
health importance because of the teratogenic effects of the 
virus on the developing fetus. When rubella is contracted in 
the fi rst trimester of pregnancy, it can cause multiple organ 
defects in the fetus and result in congenital rubella syndrome 
(CRS), miscarriage or fetal death.1 The risk of congenital 
anomalies is rare when maternal infection occurs after the 
20th week of pregnancy.2 Up to 50% of infections may be 
sub-clinical or unapparent, and thus are unrecognised.3
CRS used to be an important public health problem in 
Singapore.4 The incidence of CRS at Kandang Kerbau 
Maternity Hospital following a community-wide outbreak 
in 1969 reached 8.5 per 100,000 deliveries from November 
1969 to December 1971.5 A post-outbreak serological 
survey of the female adult population revealed an immunity 
level against rubella of only 50% to 60%.6 The low 
seroprevalence of rubella in women 15 to 40 years of age 
was confi rmed in a study conducted between January 1975 
and December 1979 when 44% to 51% of 2965 subjects 
tested negative for rubella haemagglutination-inhibition 
antibody.7 Another 2 outbreaks of rubella occurred in 
1975 and 1978, both started among national servicemen 
returning from overseas training and rapidly spread from 
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Introduction: We reviewed the epidemiological features of rubella in Singapore and the im-
pact of the national immunisation programme in raising the population herd immunity against 
rubella, with special reference to females in the reproductive age group, and in the elimination 
of congenital rubella syndrome (CRS). Materials and Methods: Epidemiological data on all 
reported cases of rubella and CRS were obtained from the Communicable Diseases Division 
and Central Claims Processing System, respectively, at the Ministry of Health. Coverage of 
the childhood immunisation programme against rubella was based on the immunisation data 
maintained by the National Immunisation Registry, Health Promotion Board. To assess the herd 
immunity of the population against rubella, 4 serological surveys were conducted from 1989 to 
1990, in 1993, 1998 and 2004. Results: The incidence of rubella has decreased signifi cantly from 
the peak of 13.3 per 100,000 population in 1996 to 1.8 per 100,000 in 2007. CRS has virtually 
disappeared. With more than 92% to 93% of primary school leavers and preschool children an-
nually vaccinated against rubella since 1976 and 1990, respectively, the level of susceptibility to 
rubella among women in the reproductive age group has gradually decreased from 44% in 1975 
to 28% in 1985, and maintained at between 10% and 20% from 1987 to 1998. A considerable 
proportion (15.8%) of women 18 to 44 years of age remained susceptible to rubella infection in 
2004. Conclusion: Rubella prevention and control has been successfully implemented. However, 
the relatively high level of susceptibility to rubella among women in the reproductive age group 
continues to be of concern. More public awareness and health educational efforts are needed 
and every opportunity should be taken to ensure that all susceptible women are identifi ed and 
protected against the infection.
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army camps to the general population.8 To eliminate CRS, 
monovalent rubella vaccine was fi rst introduced into the 
national immunisation programme for pre-adolescent 
female primary school leavers (aged 11 to 12 years old) in 
November 1976. This was subsequently extended to male 
primary school leavers and national service recruits in April 
1982 as periodic outbreaks of rubella with high sickness-
absenteeism among national servicemen had affected 
training schedules.9 Moreover, infected soldiers continued 
to be a potential source of infection to susceptible females 
in the reproductive age group.8
In January 1990, the selective rubella vaccination was 
extended to include all children of 1 year of age when 
the childhood immunisation programme against measles 
using the monovalent measles vaccine was replaced by the 
trivalent measles, mumps and rubella (MMR) vaccine. The 
monovalent rubella vaccine given to both male and female 
primary school leavers continued until it was replaced by 
the second dose of MMR vaccine in 1998. 
The objectives of this study were to review the 
epidemiology of rubella in Singapore, the impact of the 
rubella immunisation programme on the elimination of CRS 
and the immune status of the population against rubella, with 
special reference to women in the reproductive age group.
Materials and Methods
Case Surveillance
The epidemiological data of all cases of rubella notifi ed to 
the Ministry of Health (MOH) under the Infectious Disease 
Act from 1991 to 2007 were collated and analysed. The 
clinical criteria for the diagnosis of rubella were provided 
in a guidebook that was made available to all medical 
practitioners.10
Cases of CRS among infants born in Singapore and 
therapeutic abortions performed for rubella infections were 
identifi ed from the Central Claims Processing System, 
a national inpatient discharge database which covered 
all hospitals in Singapore. The discharge diagnosis was 
based on the International Classifi cation of Diseases, Ninth 
Revision (ICD-9), code 771.0. A case of CRS was defi ned 
as a clinically compatible case with a positive laboratory 
test [isolation of rubella virus or seroconversion or presence 
of rubella-specifi c immunoglobulin M (IgM) antibody]. All 
the CRS cases detected were investigated.
Immunisation Coverage
The annual MMR immunisation coverage of each cohort 
of Singapore citizens and permanent residents aged 2 years 
old from 1995 to 2007 was obtained from the National 
Immunisation Registry (NIR). In the case of primary school 
leavers, data on the proportion of children aged 11 to 12 
years immunised against rubella were obtained from the 
School Health Service of Youth Health Division, Health 
Promotion Board. 
Serological Surveys
To assess the herd immunity of the population against 
rubella, 4 seroepidemiological surveys were conducted; 
the fi rst from 1989 to 1990 just prior to the introduction 
of the trivalent MMR vaccine into the national childhood 
immunisation programme,11 the second in 1993,12 the third 
in 199813 and the last in 2004.14 In the fi rst 3 surveys, blood 
samples were collected from healthy children and adults 
aged between 6 months and over 45 years old at designated 
government polyclinics after consent had been obtained. 
Rubella agglutination IgG antibodies were analysed by the 
microparticle enzyme immunoassay (Abbott-Rubella IgG 
2.0) at the Department of Pathology, Singapore General 
Hospital.
The last survey was based on stored blood samples of the 
National Health Survey (NHS 2004)15 collected between 
September and December 2004. The NHS 2004 was 
approved by the Institutional Review Board (IRB) Ethics 
Committee of the Health Promotion Board, Singapore. 
Details of the survey which was representative of the general 
population aged 18 to 74 years old have been described 
elsewhere.16 All eligible participants had consented to have 
their residual sera used for further research. Sera from these 
participants, stored at -80oC at the Department of Pathology, 
Singapore General Hospital, were sent to the Department 
of Laboratory Medicine, National University Hospital for 
analyses. The titre of rubella IgG antibody was determined 
using Abbott AXSYM system rubella IgG assay (Abbott 
Park, IL), a microparticle enzyme immunosay. A titre of 
10 IU/mL or greater was considered positive. 
Statistical Analysis
For the calculation of annual age-specifi c incidence rates, 
the denominators used were the corresponding estimated 
mid-year populations compiled by the Department of 
Statistics, Singapore. The annual incidence rates of infants 
with CRS were calculated based on the number of live-births 
of the corresponding years obtained from the Registry of 
Births and Deaths.
Differences in rubella seropositivity rates by age, 
gender and ethnicity were computed and tested for 
statistical signifi cance using the Z-test for 2 independent 
proportions. Univariate analysis was performed using 
2 test for categorical data. Multivariate analysis using 
logistic regression was also carried out to identify socio-
demographic profi les signifi cantly associated with the 
presence of rubella seropositivity. Statistical analyses 
were performed using SPSS Software Version 15.0 (SPSS 
Chicago, IL). A P value less than 0.05 was considered 
statistically signifi cant.
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Results
Epidemiology
A 3-year cyclical pattern in rubella incidence was observed 
during the period from 1991 to 1999, with high incidence 
in 1993 (12.8 per 100,000 population), 1996 (13.3 per 
100,000 population) and 1999 (10.9 per 100,000 population) 
(Fig. 1). This was followed by a signifi cant decline to an 
incidence of 2.1 per 100,000 population in 2003 (P <0.05, 
2 test for trend), and 1.8 per 100,000 population in 2007.
The incidence rate was highest in preschool children 
aged below 5 years which constituted 24.1% to 38.1% 
of the reported cases, except in 1999 and 2000 (Table 1). 
The higher incidence rate in older children and adults in 
these 2 years was due to several institutional outbreaks (2 
or more epidemiologically related cases) involving mainly 
unvaccinated foreign students, offi ce and factory workers. 
Most of the cases (55%) in the 0 to 4 year-old age group 
were contributed by infants below 1 year of age who are 
not eligible for MMR vaccination.
The mean annual incidence rate of foreigners (6.8 per 
100,000) was higher than that of each of the 3 major ethnic 
groups of local residents (Chinese, 4.0 per 100,000; Malays, 
4.9 per 100,000; Indians, 1.3 per 100,000). The overall 
rate for males (4.9 per 100,000) was higher than that for 
females (4.1 per 100,000).
The incidence of rubella among women in the reproductive 
age group of 15 to 44 years old had decreased from 13.5 per 
100,000 population in 1996 to 2.1 per 100,000 population in 
2007 (Fig. 2). Correspondingly, the proportion of therapeutic 
Table 1. Age-Specifi c Incidence Rates per 100,000 Population of Reported Rubella Cases, 1998-2007
Age   1998  1999 2000 2001 2002 2003 2004 2005 2006 2007 
group  (y) (n = 179)  (n = 432) (n = 312) (n = 242) (n = 152) (n = 88) (n = 141) (n = 139) (n = 90) (n = 83) 
0-4 21.5  (30.2)  11.5 (6.5)  2.5 (1.9)  28.0 (27.3)  25.2 (38.1)  14.5  (36.4)  15.7  (24.1)  19.4 (29.5)  14.9 (34.4)  11.0 (27.7)  
5-9 4.4 (6.7)  3.3  (2.1)  6.7 (5.8)  5.6 (6.2)  4.1  (7.2)  1.2 (3.4)  0.4  (0.7)  2.8  (5.0)  1.2 (3.4)  0.0  (0.0)  
10-14 6.6 (8.4)  7.8  (4.4)  25.3 (20.2)  6.1  (6.6)  10.7 (19.1)  2.9 (9.1)  3.7  (7.1)  2.6 (5.0)  1.5  (4.4)  1.1  (3.6)  
15-24 5.2 (17.9)  20.5 (28.7)  13.2 (26.3)  6.4 (16.9)  4.2  (17.1)  2.3 (15.9)  3.7 (16.3)  2.9  (13.7)  2.8  (21.1)  2.5  (21.7)  
25-34 3.9  (19.5)  11.3 (22.9)  11.3  (31.7)  5.2 (19.0)  1.9  (11.2)  2.0 (19.3)  4.0 (24.1)  3.4  (20.9)  2.5  (24.4)  2.2 (25.3)  
35-44 2.9  (11.7)  12.2 (21.1)  4.6 (11.2)  5.8  (18.6)  1.3  (6.6)  1.1  (9.1)  2.5  (13.5)  2.9  (15.8)  0.4 (3.4)  0.9 (8.4)  
45-54 1.1  (5.6)  6.3 (14.3)  0.9  (2.9)  1.2  (5.4)  0.1  (0.7)  0.5  (6.8)  1.7 (14.2)  1.1  (10.1)  0.6  (8.9)  0.8 (13.3)  
Total 4.6 (100.0)  10.9 (100.0)  7.7 (100.0)  5.8 (100.0)  3.6 (100.0)  2.1  (100.0)  3.4  (100.0)  3.3 (100.0)  2.0  (100.0)  1.8 (100.0)  
Figures in brackets refer to percentage of total cases in the corresponding year.
Fig. 1. Rubella incidence (per 100,000 population) and MMR immunisation 
coverage, 1991-2007. 
Fig .2. Rubella incidence of women aged  15-44 years (per 100,000 population) 
and proportion of therapeutic abortions performed on account of rubella 
infections, 1991-2007. 
Fig . 3. Age-specifi c prevalence of antibody to rubella in Singapore, based on 
serological surveys conducted in 1989-90, 1993, 1998 and 2004.
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abortions performed on account of rubella infections had 
decreased from 0.10% in 1996 to 0.01% in 2007. The 
overall correlation between the incidence of rubella among 
women aged 15 to 44 years old (per 100,000 population) 
and proportion of therapeutic abortions performed on 
account of rubella infections from 1991 to 2007 was found 
to be statistically insignifi cant (P >0.05). However, there 
were some years that the pattern corresponded quite well, 
such as in 1996.
The incidence of CRS declined from 0.08 per 1000 live-
births in 1992/1993 to 0.03 per 1000 live-births in 2004 
(Table 2). No cases of CRS were reported in 1997, 1998, 
2000, 2003, 2004, 2006 and 2007. The number of therapeutic 
abortions performed on account of rubella infections also 
dropped markedly from 30 cases in 1991 to 1 in 2007.
Immunisation Coverage
The annual MMR immunisation coverage among 
Singapore citizens and permanent residents at 2 years of 
age had been maintained at a high level (93% to 98%), 
even in 2003 when an outbreak of severe acute respiratory 
syndrome (SARS) occurred (Fig. 1).17 In the case of primary 
school leavers, the annual coverage rate had been above 
93% (93% to 96%).
Seroepidemiology
A total of 500 children and adults between 6 months and 
over 45 years of age were tested for rubella IgG antibody 
during the 1989 to1990 survey. The seroprevalence of rubella 
was low in children below 10 years of age (7% to 11%). 
It doubled from 42% in the 10 to 14 year-old age group to 
90% in the 15 to 19 year-old age group and maintained at 
above 80% in adults, except in the 35 to 44 year-old age 
group which had a prevalence of 60% (Fig. 3).
In the 1993 survey, sera from 909 children and adults 
aged 6 months to over 45 years old were analysed. The 
seroprevalence increased from 69.9% in 1 year-old infants 
to 97.9% in children aged 2 to 3 years old. It then declined 
to 70.8% in the 4 year-olds and 27.5% in children aged 
5 to 9 years old. The seroprevalence was 62.5% in older 
children aged 10 to 14 years of age and it attained a very 
high level of 94.4% in the age group of 15 to 19 years old 
before it dropped again to 80.3% in adults above 45 years 
of age (Fig 3).
The serological survey conducted in 1998 coincided with 
the implementation of the ‘catch-up’ measles vaccination 
programme for adolescents aged 12 to 18 years old using 
the MMR vaccine in 1997, and the introduction of the 
second dose of MMR vaccine to all primary 6 school 
children in 1998.18 Sera obtained from 928 children and 
adults from 6 months to over 45 years of age were tested. 
The seroprevalence was between 87.4% and 96.6% among 
those aged 15 to 34 years old, and then maintained at 77.3% 
to 78.4% in adults aged above 35 years old (Fig 3).
Compared to the serological survey conducted prior to the 
introduction of the trivalent MMR vaccine in 1990, there 
had been a signifi cant increase in the overall prevalence 
of antibody to rubella among healthy children and adults 
aged between 6 months and over 45 years old from 47.6% 
in 1989 and 1990 to 71.7% in 1993, and 80.2% in 1998 
(P <0.05, 2 test for trend). The increase in seroprevalence 
in the 5 to 9 year-old age group was most marked across all 
surveys; the seroprevalence in this age group was 27.5% in 
1993, which was more than double that in 1989 and 1990 
(11.0%), and it increased by more than 3 times to 86.4% 
in 1998 (P <0.05, 2 test for trend). The seroprevalence 
in the 10 to 14 year-old age group was also signifi cantly 
higher at 62.5% in 1993, compared to 42% in 1989 and 
1990 (P <0.05). The antibody prevalence in the 15 to 24 
year-old age group increased from 85% in 1989 and 1990 
to 93.4% in 1993 and 95.8% in 1998 (P <0.05, 2 test 
for trend).
In NHS 2004, of 4152 adult resident population aged 
18 to 74 years old tested for rubella IgG antibody, 84.0% 
(95% CI, 82.9%-85.1%) were seropositive. While the 
proportion of women aged 15 to 44 years old susceptible 
to rubella infection decreased from more than 20% in the 
Table 2. Incidence of CRS and Therapeutic Abortions Performed on 
 Account of Rubella Infection, 1991-2007
Year CRS Total no. of  No. of therapeutic  
  abortions abortions performed
   on account of 
    rubella infections 
 No. Per 1000  No. (%) 
   live-births 
1991 1 0.02  17,798 30 0.17 
1992 4 0.08  17,073 21 0.12 
1993 4 0.08  16,476 8 0.05 
1994 2 0.04  15,690 10 0.06 
1995 2 0.04  14,504 9 0.06 
1996 2 0.04  14,365 15 0.10 
1997 0 0.00  13,827 5 0.04 
1998 0 0.00  13,838 2 0.01 
1999 2 0.05  13,753 6 0.04 
2000 0 0.00  13,754 2 0.01 
2001 2 0.05  13,140 3 0.02 
2002 1 0.02  12,749 0 0.00 
2003 0 0.00  12,272 0 0.00 
2004 0 0.00  12,070 2 0.02 
2005 1 0.03  11,482 0 0.00 
2006 0 0.00 12,032 3 0.02 
2007 0 0.00 11,933 1 0.01 
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period of 1989 to 1990 to 17% in 1993, and 13.6% in 1998, 
a signifi cant proportion of women in the reproductive age 
group remained susceptible to rubella infection (15.8% 
seronegative) in 2004. There was no signifi cant ethnic 
difference in susceptibility to rubella among this group 
of women (Chinese, 15.8%; Malays, 13.8%; and Indians, 
16.7%). Based on univariate analysis and multivariate 
analysis using logistic regression, no signifi cant differences 
in socio-demographic profi les among women of all ages and 
women in the reproductive age group were found. Using 
“year of birth before 1964” (>12 years old in 1976) as a 
proxy indicator, no signifi cant difference was detected in the 
seroprevalence among females born before or after 1964.
Discussion
The incidence of rubella has been declining from 13.3 per 
100,000 in 1996 to 1.8 per 100,000 in 2007. This decreasing 
trend can be attributed to the comprehensive coverage of 
the childhood rubella immunisation programme in which 
more than 93% of children aged 1 to 2 years old are annually 
vaccinated. The impact of the national immunisation 
programme against rubella was also refl ected in the fi ndings 
of the periodic serological surveys conducted in the period 
of 1989 to 1990, 1993 and 1998 which showed increasing 
prevalence of rubella antibodies among preschool and 
primary school leavers vaccinated. Moreover, from the 1993 
serological survey, the high seroprevalence of 93.4% in the 
15 to 24 year-old age group confi rmed the immunogenicity 
of the monovalent rubella vaccine. Between 91.3% and 
98.7% of this age cohort was vaccinated with the monovalent 
rubella vaccine at 11+ years of age during the period of 
1977 to 1993.12
Based on mathematical modelling, rubella virus 
transmission in children may be eliminated with a 
vaccination coverage rate of about 90%.19 In fact, outbreaks 
in army camps had virtually disappeared following routine 
vaccination of male primary school leavers and national 
service recruits in 1982.20 More than 97% of a cohort of 
national service recruits tested in 1994 was found to possess 
rubella antibodies.21 
Rubella continues to affect the unvaccinated population; 
viz infants below 1 year of age who are not eligible for 
immunisation, local residents who are not covered under 
the national immunisation programme which started in 1976 
for female primary school leavers of 12 years of age, and 
foreign students and workers from countries where there 
is no immunisation programme against rubella or where 
the immunisation coverage may be low.
The primary objective of the rubella immunisation 
programme is to prevent CRS.22 Such immunisation 
programmes have eliminated or greatly reduced the 
incidence of rubella and CRS in developed countries.23,24 
The World Health Organisation (WHO) has set a target to 
reduce the incidence of congenital rubella infection in the 
European Region to less than 1 per 100,000 live-births by 
2010.25 In Singapore, the incidence of congenital rubella 
dropped sharply from 16 cases in 1976 to 10 cases in 
1983, 2 cases in 1987 and it has virtually disappeared in 
recent years.20 The annual number of therapeutic abortions 
performed on account of rubella infection has also decreased 
from between 45 and 77 cases in the 1970s and 1980s to 
virtually none in the last few years. While Singapore is on 
track towards achieving the WHO target for the European 
Region, there is no room for complacency.
Of concern is the considerably high proportion of women 
of reproductive age who remain non-immune despite the 
high coverage of the childhood rubella immunisation 
programme over the last 3 decades. Although the level of 
susceptibility in women aged 15 to 44 years old has dropped 
from 44% in 1975 to 28% in 1985, and maintained at between 
10% and 20% from 1987 to 1998, the NHS 2004 revealed 
that 15.8% of women aged 18 to 44 years old were non-
immune to rubella infection. This level is relatively high 
compared to women of reproductive age (15 to 39 years 
old) in Australia and 16 countries in the WHO European 
Region in 2003, for example, it was 2.7% in Australia, 6.2% 
in England and Wales, 2.2% in Sweden,26 and 9.6% among 
women of foreign nationality and 3.5% among the local 
population in Switzerland.27 When compared with women 
of reproductive age in some Asian cities, Singapore has a 
non-immunity level higher than that in Taipei (10.9% in 
women aged 15 to 44 years old in 2004),28 but lower than 
that in Seoul (26.9% in female university students aged 18 
to 26 years old in 1996).29
No signifi cant difference in susceptibility to rubella was 
detected amongst women of the pre-vaccination cohort 
(pre-1964) and those of the post-vaccination cohort (post-
1964). One possible explanation for this observation is 
the rise in immigrants and non-residents from rubella 
endemic countries in Singapore. As we do not have the 
breakdown of the residents in terms of Singapore citizens 
born in Singapore and Singapore permanent residents 
who originated from other countries where the rubella 
immunisation programme might not be as comprehensive 
as in Singapore, we are unable to fully examine the impact 
of high levels of immigration on the overall level of herd 
immunity in Singapore.
The growing immigration in developed countries is known 
to pose a higher risk of rubella virus transmission due to 
the introduction of groups of unprotected individuals.30 The 
incidence rate of rubella among foreigners in Singapore is 
higher than that of local residents, and localised transmission 
has occurred in settings where unvaccinated susceptible 
populations congregate such as schools, factories and offi ces. 
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A high degree of vigilance should therefore be maintained 
in such settings where susceptible foreigners congregate.
Greater focus on protecting the population at greatest risk, 
that is, women in the reproductive age group is needed, as 
the risk of infection in pregnant women constitutes the public 
health burden of rubella.31,32 Every opportunity for health 
education and vaccination against rubella should be taken to 
ensure that all susceptible women, including immigrants and 
non-residents, are protected. Exposed pregnant women with 
low-level immunity to rubella could be at risk of re-infection 
of wild-type rubella.33 The current rubella immunisation 
programme will be further strengthened and extended. These 
include premarital screening for rubella antibody to identify 
susceptible women before pregnancy,34 and vaccination of 
susceptible women in the reproductive age group as part of 
the routine general medical and gynaecological outpatient 
care.35 Foreign students should also be routinely checked 
not only for the compulsory measles vaccination, but also 
rubella vaccination which is offered voluntarily.
We would like to point out that in this study, only 14% to 
32% of the reported rubella cases had the clinical diagnosis 
verifi ed by laboratory tests. Rubella is clinically similar to 
a number of other viral infections. In an ad-hoc study of 
a sample of 114 notifi ed cases of measles, 42.1% turned 
out to be rubella.36 Moreover, in the interpretation of IgM 
antibody results, non-specifi c fi ndings are not uncommon 
as the antibody may cross-react with other viral infections 
such as parvovirus B19, cytomegalovirus and Epstein-
Barr virus.11 It should also be noted that the serological 
surveys of the period of 1989 to 1990, 1993 and 1998 were 
not representative of the general population and that the 
laboratory tests for the detection of IgG rubella antibodies 
were not the same in the various surveys conducted. 
Nevertheless, these surveys have provided evidence of 
the changing trends in the age-specifi c seroprevalence of 
rubella following the introduction of the national childhood 
immunisation programme and the implications of the 
fi ndings in women of reproductive age.
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